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ABSTRACT We studied the antigen-presenting capacity of
mouse L fibroblasts transfected with genes encoding Ta
polypeptides of the major histocompatibility complex (MHC).
These cells function as efficient antigen-presenting cells (APC)
in stimulating peptide antigen-specific MHC-restricted prolif-
eration of long-term T-cell lines, thus establishing the capacity
of Ia-expressing L-cell transfectants to present antigens to
apparently normal T cells. However, in contrast to splenic
APC, L-cell transfectants fail to present native hen egg-white
lysozyme to the same T cells. Since this result is similar to that
obtained with physiologic APC pretreated to prevent antigen
degradation, it suggests that L-cell transfectants, without such
pretreatments, may be compromised in their ability to process
native lysozyme. However, since such transfectant cells have
been shown to present other complex polypeptides such as
keyhole limpet hemocyanin, a random copolymer of glutamic
acid, alanine, and tyrosine, and influenza virus neuraminidase,
this observation suggests that protein antigens differ in the
stringency of processing requirements.
The I-A and I-E molecules, together known as the Ta
molecules, are encoded within the major histocompatibility
complex (MHC). These molecules serve key functions in
regulating the activation of T helper lymphocytes. Phenom-
ena such as restriction of antigen recognition, alloreactivity,
and many immune response gene defects are known to be
profoundly influenced by the extremely polymorphic Ta
molecules (for reviews, see refs. 1 and 2). T cells can be
stimulated to proliferate or secrete lymphokines, such as
interleukin 2 (IL-2), only by antigen-presenting cells (APC)
expressing the appropriate Ta molecule. In most instances,
T-cell stimulation requires both antigen and a particular Ta
molecule. Structural changes in the Ta molecules, such as
those that occur naturally as polymorphic differences among
inbred H-2 recombinant mouse strains, do not lead to T-cell
stimulation, even when the same antigen is employed. This
strict specificity for a particular Ia allele is known as MHC
restriction of antigen recognition. The structural features of
the a and p subunits of the la molecules, relevant to
MHC-restricted activation, are not well defined.
Recent advances in cloning the genes of the a and p
subunits of the Ta molecule and their expression in cells that
normally do not express Ia gene products have allowed a
direct approach to the study of the structure-function rela-
tionships of the Ta molecule (3-8). It has been shown that
mouse fibroblasts transfected with the genes of the murine la
or human DR polypeptides can express the molecules on the
cell surface. Moreover, these Ia-expressing transfectants are
capable of stimulating several antigen- and allo-specific T
cells in an MHC-restricted manner (5-8).
In this report, we extend these studies to long-term
antigen-specific T-cell lines to demonstrate that both I-Ak_
and I-Ek-expressing L-cell transfectants present a lysozyme
peptide in an MHC-restricted manner. For I-Ek-restricted T
cells, the Ep subunit was found to determine the MHC
restriction specificity. However, the same transfectant cells
were incapable of presenting native lysozyme to the same T
cells. This result is similar to the results obtained with APC
pretreated with either lysosomotropic drugs or aldehydes;
such cells were also found to present peptides derived from
protein antigens but not the native proteins themselves
(9-11). Thus it would appear that Ia-expressing mouse
fibroblasts, though capable of providing all of the specificity
requirements for normal T-cell activation, are compromised
in their ability to process native lysozyme.
MATERIALS AND METHODS
Mice. CBA/J and C3H/HeJ mice were obtained from The
Jackson Laboratory and bred in our colony. Animals ofeither
sex were used at 3-12 months of age.
Antigens. Purified hen egg-white lysozyme (HEL) was a
kind gift ofA. Miller and E. Sercarz (University of California,
Los Angeles). The T11(H) peptide (amino acids 74-96 of
HEL) was prepared by solid-phase synthesis as described
elsewhere (12).
T cells. The T-cell lines and clones used in this study are
listed in Table 1. These long-term T-cell lines and T-cell
hybrids were generated according to described methods
(12-14).
Transfected Fibroblast Cell Lines. The parental Ltk- cell
line and five different transfected cell lines were used in this
study (Table 1). The transfectants were generated by
cotransfer of the genes of Ta subunits and the thymidine
kinase (tk) gene as a selectable marker in the mouse Ltk-
fibroblast cell line. The transfection procedures and selection
of clones CA14.11.14, CA14.11.29, and CA14.11.35 have
been described extensively (3, 6). The I-E-expressing cell
lines were constructed in a similar way using the Ek and E d
genes (CA36.2.1) or the Ea and E/k genes (CA36.1.3). The
E/k gene was derived from a construct consisting of the
leader exon from the Ed gene and the remainder of the
molecule from the Ek gene (unpublished data). As the leader
peptide is excised prior to cell surface expression (leaving
three apparently silent amino acid substitutions in the Ek
NH2-terminal region), and the E. and E. subunits are almost
identical (15, 16), the expressed Ed/k and EkEd molecules are
referred to here as E and I-Ed, respectively.
The cell surface expression of the expected determinants of
the I-E molecules on these two cell lines was analyzed by
Abbreviations: APC, antigen-presenting cells; HEL, hen egg-white
lysozyme; IL-1 and IL-2, interleukin 1 and interleukin 2; MHC,
major histocompatibility complex; T11(H), amino acids 74-96 of
HEL.
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Table 1. Cell lines used in this study
Mouse strain Antigen MHC Ia
Designation Cell type of origin specificity restriction expression
KOIT Long-term bulk T line CBA T11(H) I-Ak
AOIC Long-term bulk T line B1O.A T11(H) I-Ek
KOIT.2.10 Long-term T clone CBA T11(H) I-Ak
AOIT.H.2 T hybridoma B10.A T cells fused T11(H) I-Ak
with AKR thymoma
(BW5147)
Ltk- Fibroblast C3H None
CA14.11.14 Transfectant fibroblast C3H I-Ak
CA14.11.29 Transfectant fibroblast C3H I-Ak
CA14.11.35 Transfectant fibroblast C3H I-Ak
not detectable
CA36.1.3 Transfectant fibroblast C3H I-Ek
CA36.2.1 Transfectant fibroblast C3H I-Ed
using the available monoclonal antibodies (17). Table 2 shows
that both CA36.1.3 and CA36.2.1 cells expressed the widely
cross-reactive determinants detected by antibodies 10.B and
39.1. However, only CA36.1.3 cells reacted with antibody
9.A, which is specific for the I-Ek molecule. This demon-
strates that the two cell types express different serological
determinants corresponding to the transferred genes. The
control antibodies 84.17.2 and 10.2.16, respectively directed
towards the endogenously expressed Kk molecule and the
unexpressed I-Ak molecule, showed the expected reactions.
Cell Cultures. The fibroblast cell lines were maintained in
a-MEM (GIBCO) supplemented with 2 mM glutamine, 1 mM
pyruvate, 50 ,uM 2-mercaptoethanol, penicillin at 100
units/ml, streptomycin at 100 ,g/ml, and 10% fetal bovine
serum (Irvine Scientific, lot 404248). All other cell lines and
cultures were maintained in similarly supplemented RPMI
1640medium (GIBCO). The cultures were incubated at 37°C in
an atmosphere of 5% C02/air.
T-Cell Stimulation Assays. Specific stimulation of long-
term T-cell lines was assessed in a proliferation assay. To
reduce background proliferation, APC (freshly prepared
spleen cells or transfected L fibroblasts) were treated with
mitomycin C (Sigma) at 50 ,ug/ml at 37°C for 30 min and were
washed four times with Hanks' balanced salt solution (BSS)
before use. T cells (1 x 104), purified by passage through
Ficoll-Paque (Pharmacia), were cultured with mitomycin
C-treated spleen cells (5 x 105) or L fibroblasts (1 x 105) in
the presence of antigen or medium alone. Incorporation of 1
ACi (1 Ci = 37 GBq) of [3H]thymidine added per culture (30
Table 2. Serological analysis of the Ia molecules present on the
surface of the L-cell transfectant lines CA36.1.3 and CA36.2.1
12I-protein A
bound,t cpm x 10-
Monoclonal Known CA36.1.3 CA36.2.1
antibody* Specificity cross-reactions (Ek, Ek) (Ek, Ed)
10.B I-Ek, Ia.7 d, v, r, p, u,j 270 279
39.1 I-Ek d, v, r, p, u, j, b, q 216 278
9.A I-Ek None 197 1.3
84.17.2 Kk 417 393
10.2.16 I-Ak, Ia.17 0.6 0,5
*The monoclonal antibodies used here were kindly provided by
Michel Pierres. The specificities of these antibodies have been
described (17).
tTransfectant cells (5 x 10-) were incubated with 50 ,ul of the
appropriate monoclonal antibody (10 ,g/ml). After 1 hr at 4°C the
cells were wished twice, resuspended with 105 cpm of '"5I-labeled
staphylococcal protein A, and incubated for an additional 45 min at
4°C. Finally, after three washes, cell-associated radioactivity was
measured in a y counter.
Ci/mmol; ICN) was assessed during the last 48 hr of a 3-day
culture. In some experiments, monoclonal anti-Ia antibody-
containing culture supernatants of 10.2.16 or 14.4.4 cells were
included in the cultures.
Stimulation of T-cell hybrid AOIT.H.2 was assessed by
estimating the IL-2 content in a 24-hr supernatant of 1 x 10
T cells cultured with APC and antigens in a total volume of
0.2 ml. Fifty microliters of the supernatant was added to 5 x
103 cells, in 50 ,ul of medium, of the IL-2-dependent cell line
HT-2 (kindly provided by J. Kappler and P. Marrack,
Denver, CO) (14). Growth of the cells was estimated by
[3H]thymidine incorporation during the last 4-8 hr of a 24-hr
culture.
RESULTS AND DISCUSSION
I-Ak-Expressing Mouse Fibroblasts Can Serve as APC for
Long-Term Antigen-Specific T-Cell Lines. Mouse L-cell fi-
broblasts do not normally carry out the functions associated
with APC for T-cell stimulation. However, when these L
cells are transfected with the genes for the Ia molecules, they
can express the Ia molecule on the cell surface and serve as
APC for MHC-restricted antigen-specific T-cell hybrids
(5-8). T-cell hybrids are known to be less stringent, com-
pared to normal T cells, in their accessory requirements such
as interleukin 1 (IL-1) for stimulation (18). It is possible that
while the expression of Ia molecule on L cells could be a
sufficient condition for stimulation of T-cell hybrids, the
same L cells may not be capable of presenting antigens to
normal T cells, because of an inherent deficiency in providing
the accessory requirements. We assessed the APC function
of the I-Ak-expressing L-cell transfectant CA14.11.14 to
present the T11(H) peptide (amino acids 74-96 of HEL) to
long-term T-cell lines specific for this peptide and restricted
by the I-Ak molecule (Table 3). For both the bulk line KOIT
and the cloned line KOIT.2.10, the I-Ak-expressing
CA14.11.14 cells were found to be efficient APC. The
untransfected Ia- Ltk- cells could not serve as APC,
indicating the necessity of Ia expression. Considering that the
APC constitute a very small (<1%) fraction of the heteroge-
neous spleen cell population, it should be noted that on a per
cell basis CA14.11.14 cells were lower in their stimulatory
capacity. The stimulation was, however, always significant
and reproducible. Recently, it was shown that murine Ia- or
human DR-expressing transfectant L cells can present pep-
tides of pigeon cytochrome c or viral neuraminidase to
long-term T-cell lines (7, 8). Taken together, these results
show that independently generated Ia-expressing L cells can
serve as APC for presentation of peptides to apparently
normal T cells and are thus capable of providing all the
accessory requirements usually associated with physiologic
APC. The interesting issue raised by these studies is the role
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Table 3. Mouse L-cell fibroblasts transfected with the genes of the Ia molecule can serve as
efficient APC for long-term antigen-specific T-cell lines
[3H]Thymidine incorporation, cpm x 10-3 per culture
Ltk- cells CA14.11.14 CBA spleen
T cells Medium T11(H) Medium T11(H) Medium T11(H)
KOIT 0.3 ± 0.1 0.2 ± 0.1 10.0 ± 0.3 68.2 ± 0.6 0.5 ± 0.2 256.3 ± 17.8
KOIT.2.10 0.2 ± 0.1 0.2 ± 0.1 10.3 ± 0.6 57.2 ± 1.2 3.5 ± 4.2 247.6 ± 3.1
T cells (1 x 104) passed through Ficoll-Paque were cultured with mitomycin C-treated syngeneic CBA
spleen cells (5 x 101), I-Ak-transfected L cells (CA14.11.14) (1 x 105), or untransfected L cells (Ltk-)
(1 x 105), in the absence (medium alone) or presence of 7 ,uM T11(H) peptide. Incorporation of 1 ACi
per culture of [3H]thymidine was assessed during the last 18 hr of the 3-day culture. Results are mean
± SEM.
of IL-1 and other accessory molecules (such as L3T4, etc.)
considered essential for normal T-cell activation (reviewed in
ref. 19). It is presently unclear whether mouse fibroblasts are
capable of providing such functions or whether these require-
ments are bypassed.
Antigen Presentation by Ia-Expressing Transfectants Is
MHC Restricted. The specificity of Ia-mediated antigen
presentation function of L-cell transfectants was assessed by
using T cells restricted by either the I-Ak or the I-Ek molecule.
Table 4 shows that the splenic APC from the CBA mouse
(expressing both the I-Ak and I-Ek molecules) can present the
T11(H) peptide to both the I-Ak-restricted clone KOIT.2.10
and the I-Ek-restricted AOIC bulk T-cell line. The ability of
the transfectant fibroblasts to present the same antigen to the
T cells was dependent upon the expression of the appropriate
Ia molecule. Thus, I-Ak-restricted KOIT.2.10 cells were
stimulated by I-Ak-expressing CA14.11.14 and 14.11.29 cells
but not by CA36.1.3 cells, which express the I-Ek molecule.
Conversely, I-Ek-restricted AOIC T cells could be stimulated
only by CA36.1.3 cells and not by any of the I-Ak-expressing
transfectants. The CA14.11.14 cells express higher levels of
cell surface I-Ak molecules compared to CA14.11.29 cells and
show a higher stimulatory capacity (6). Transfectant
CA14.11.35 (thymidine kinase-positive) cells do not express
detectable levels of Ia and were quite incapable of serving as
APC, suggesting a correlation between the quantitative
expression of cell surface Ia molecules and the stimulatory
capacity of the transfectants. Thus, in agreement with the
earlier studies, the transfection procedure does not by itself
convert the fibroblasts into APC, but requires the expression
of cell surface Ia molecules.
Further evidence for the direct involvement of the la
molecule in the APC function was obtained by using mono-
clonal anti-Ia antibodies to inhibit this function. Proliferation
of I-Ak- and I-Ek-restricted KOIT.2.10 and AOIC T cells,
induced by the T11(H) peptide, in the presence of the
appropriate Ia-expressing L cells, could be reciprocally
inhibited by antibodies directed towards either the I-Ak or the
I-Ek molecules (Table 5). This demonstrates the direct
involvement of the Ta molecules in APC function and, taken
together with the correlation between stimulatory capacity
and quantitative surface expression (20), supports the view
that the antigenic peptide and the Ta molecule together
constitute all of the specificity requirements necessary for
T-cell receptor recognition (1, 14). This has recently been
elegantly confirmed by the success in antigen-specific stim-
ulation of T-cell hybrids by using purified Ia molecules
incorporated in planar membranes (21).
Restriction Specificity of the I-E Molecule Is Determined by
the P Subunit. One of the advantages in using the transfected
mouse fibroblasts instead of other tumor cell lines as APC
(22, 23) lies in the ability to manipulate predetermined
structural features of the Ia molecule by altering the genes
used for transfection. Such transfectants, expressing specif-
ically altered Ia molecules, would be invaluable in mapping
the structural features of the Ta molecule relevant to the
MHC-restricted activation process. Moreover, functional
studies have suggested that the Ia molecules exhibit multiple
restriction sites (24, 25). However, the location of these sites
on the Ia molecule is not known. As a beginning in the
analysis of structural correlates of Ia function, we transfected
mouse L-cell fibroblasts with the genes for either the Ek and
E (cell line CA36.1.3) or the Ek and Ed (CA36.2.1) mole-
cules. Since the Ea molecules of the k and d haplotypes are
almost identical (16), it was expected and shown by serolog-
ical analysis with monoclonal antibodies that CA36.1.3 and
CA36.2.1 cells express determinants expected of the I-Ek and
I-Ed molecules, respectively (Table 2). Table 6 shows that the
antigen-induced proliferative response of I-Ek-restricted
AOIC T cells could be obtained only with EkEk-expressing
CA36.1.3 and not with E.E'o-expressing CA36.2.1 cells. The
latter CA36.2.1 cells have been shown to stimulate antigen-
specific I-Ed-restricted T-cell hybrids (unpublished data).
This confirms the previous genetic and structural analyses
and suggests that the restriction specificity of the I-E mole-
cule correlates with the more polymorphic 1B subunit (26).
Table 4. L-cell antigen presentation function requires the expression of the appropriate
gene product
[3H]Thymidine incorporation, cpm x 10-3 per culture
KOIT.2.10 AOIC
APC Ia expression Medium T11(H) Medium T11(H)
CBA spleen I-Ak I-Ek 1.9 ± 1.9 108.4 ± 5.6 1.9 ± 3.6 207.3 ± 10.1
CA14.11.14 I-Ak - 2.6 ± 0.3 76.6 ± 2.3 2.0 ± 0.3 8.7 ± 0.8
CA14.11.29 I-Ak - 2.8 ± 0.1 44.5 ± 1.7 2.7 ± 0.2 5.3 ± 0.2
CA36.1.3 I-Ek 12.0 ± 0.2 7.1 ± 0.2 12.3 ± 3.3 110.2 ± 4.0
CA14.11.35 - 4.9 ± 0.1 4.7 ± 0.1 4.7 ± 0.3 5.5 ± 0.4
T11(H)-specific I-Ak-restricted KOIT.2.10 and I-Ek-restricted AOIC T cells were assayed for
antigen-induced proliferative response, using different la-transfected L cells and CBA spleen cells as
APC. Culture conditions were identical to those in the legend to Table 3.
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Table 5. Ia L-cell antigen presentation function involves the
expressed Ia molecule
[3H]Thymidine incorporation,
Monoclonal Acpm x 1i-0 per culture
antibody Specificity KOIT.2.10 AOIC
- 114.9 ± 2.3 160.1 ± 2.4
10.2.16 I-Ak 4.0 ± 1.4 135.3 ± 3.9
14.4.4 I-Ek 128.1 ± 4.5 7.3 ± 0.2
I-Ak-restricted KOIT.2.10 and I-Ek-restricted AOIC cells were
cultured with, respectively, I-Ak- and I-Ek-expressing CA14.11.14
and CA36.1.3 L cells in the presence of 7 AuM T11(H). Culture
conditions were identical to those in the legend to Table 3. Back-
ground cpm with medium alone were 3.6 x 103 for KOIT.2.10 and 7.9
x 103 for AOIC; these have been subtracted. Monoclonal antibodies
10.2.16 and 14.4.4 were included in the cultures at a dilution of 1:100.
The generality of this conclusion for other antigens and a
more precise definition of the relevant regions of the E,
subunit affecting reactivity must await further studies.
la-Transfected Fibroblasts Fail to Present Native Lysozyme
to T Cells. While it is clear that the Ia molecule serves a
specific role in the activation of T cells, the antigen presen-
tation phenomenon involves events that must occur prior to
the recognition event (reviewed in ref. 27). Such events,
referred to as antigen processing, have been distinguished
from the recognition event by the use of either lysosomo-
tropic drugs or aldehyde-fixed APC. Under these conditions,
it has been found that APC fail to present native protein
antigens, whereas the presentation of smaller peptides, and in
some cases denatured proteins, to T cells is not affected
(9-11). The molecular mechanisms through which the APC
degrade and eventually present antigen fragments in the
context of the Ia molecule on the cell surface apparently
involve lysosomal pathways that are poorly understood (27).
In the other studies, T-cell responses to large complex
polypeptide antigens such as keyhole limpet hemocyanin,
random polymer of glutamic acid, alanine, and tyrosine
(GAT), and viral neuraminidase could be readily obtained
with Ia-expressing L fibroblasts (5-8). This suggested that
the fibroblasts possessed the capacity to process these
antigens. This was also supported by the known antigen-
processing requirements of some of these T cells (9). Nev-
ertheless, T-cell clones specific for ovalbumin and lysozyme
could not be stimulated by the same transfectant L cells (6,
7). The reasons for these failures could be attributed to
differences between the T-cell interactions with the physio-
logic APC versus the L-cell transfectants, presumably due to
their distinct differentiation lineages (leukocyte versus fibro-
blast). This difference could relate to any combination of
parameters such as inadequate processing, lack of target
structures for T-cell accessory molecules (L3T4, LFA-1,
etc.), inability to provide sufficient lymphokine activities,
etc., all known to be involved at different stages of the
activation process (reviewed in ref. 19).
As the nominal antigen specificity of the T cells used by us
was known to reside within amino acids 74-96 of HEL, we
evaluated the ability of Ia-expressing L fibroblasts to process
Table 6. The Ep subunit determines the MHC specificity of
I-Ek-restricted AOIC T cells
[3H]Thymidine incorporation,
cpm x 10-3 per culture
APC I-E Medium T11(H)
100
0
1.= 80-
60
0
._1
c-
10x 40-
=u20-
T11(H)
, Spleen
-1 A14.11.14
0.7 3.5 7.0
HEL
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FIG. 1. T11(H)- versus native HEL-induced proliferative re-
sponse of long-term KOIT.2.10 T cells. T cells were cultured in
medium alone or in the presence of various concentrations of soluble
peptide T11(H) or native HEL. Mitomycin C-treated CBA spleen
cells (o) or I-Ak-transfected L cells, CA14.11.14 (o) were used as
APC. Culture conditions were the same as in the legend to Table 3.
Background incorporation with medium alone was 0.5 x 103 cpm for
CBA spleen cells and 8.4 x 103 cpm for CA14.11.14 and has been
subtracted. Bars indicate ±SEM.
and present this determinant present in the native HEL
primary sequence to T cells. Fig. 1 compares the APC
function of freshly prepared CBA spleen cells to that of
I-Ak-expressing CA14.11.14 cells. While the T11(H) peptide
was efficiently presented by both sources of APC, the
transfectant L cells, in contrast to splenic APC, were inca-
pable of presenting native HEL to the same T cells.
In this experiment, we had used spleen cells from the CBA
strain as the source of APC because they are syngeneic with
the CBA-derived T-cell clone KOIT.2.10. The L-cell fibro-
blasts are, however, derived from the C3H mouse. To
address possible variations in the ability of APC from
different mouse strains to present antigens to T cells (28), we
compared APC from the C3H spleen and CA14.11.14 cells.
To assess the possibility that this phenomenon was related to
the fact that we had used long-term T cells, we employed a
T-cell hybrid clone AOIT.H.2, similar to T-cell hybrids used
in some of the other studies. This clone is specific for the
same T11(H) peptide and is restricted by the I-Ak molecule
(Table 1). Fig. 2 shows the IL-2 response of the T-cell hybrid
cells cultured with either C3H spleen cells or CA14.11.14
cells in the presence of the T11(H) peptide, native HEL, or
both. Again, the L-cell transfectants, in contrast to the
syngeneic C3H splenic APC, completely failed to present
HEL, even at a supraoptimal dose of 70 ,uM. Both cell types
were capable of presenting the T11(H) peptide at similar
concentrations. Furthermore, the inability to present HEL
was not due to a selective inhibition of L-cell APC function,
as shown by the negligible effect of inclusion of HEL in the
T11(H)-stimulated cultures. It thus appears that L cells are
unable to present the same T11(H) peptide when it is part of
the native structure of HEL.
This result is analogous to the results obtained with several
protein antigens, including lysozyme, using physiologic APC
pretreated with lysosomotropic drugs or aldehydes (9-11). It
should be emphasized that no such pretreatments were
necessary with the L-cell transfectants. The possibility that
mitomycin C pretreatment of the APC, carried out to prevent
background proliferation, selectively interfered with the
presentation of HEL was ruled out by using untreated
transfectant L cells and AOIT.H.2 hybrid cells (data not
shown). The similarity in the response phenotypes of pre-
treated physiologic APC and untreated L-cell transfectants
suggests that the latter may be inherently compromised in
their ability to process native HEL. It is interesting that these
CA36.1.3 EkE 8.0 ± 0.5 145.0 ± 2.6
CA36.2.1 EkE 6.6 ± 0.2 5.3 ± 1.0
Culture conditions were the same as in legend to Table 3.
5888 Immunology: Shastri et al.
k
Proc. Natl. Acad. Sci. USA 82 (1985) 5889
C3H spleen
;T11(H)
70
Antigen,
CA14.11.14
7 gM
-~~~~TT T11(H)T11(H) T11+H
HEL
L wo" 15 8 b HEL
00.7 3.5 7 70
kM
FIG. 2. Presentation of the Tll(H) peptide and/or native HEL by
,C3H strain spleen cells or I-Ak transfectant CA14.11.14 cells to T-cell
hybridoma AOIT.H.2. Culture conditions were the same as in the
legend to Table 3 except that 1 x 105 T cells were used. Antigens were
included at the indicated concentrations. T1I(H) (e), HEL (o), and
7 ,uM T11(H) were included with indicated concentrations of HEL
(A). Thymidine counts shown are those incorporated by the IL-2-
dependent HT-2 cell line cultured with the 24-hr supernatant from
each well of the primary culture and are a measure of the IL-2
secreted by the stimulated T-hybrid cells. Bars indicate ±SEM.
and similar transfectants have been shown to be capable of
presenting other complex polypeptide antigens, such as
keyhole limpet hemocyanin, poly(Glu, Ala, Tyr), and viral
neuraminidase, to T cells under similar experimental condi-
tions (5-8). It then follows from the known involvement of
lysosomal degradation pathways in antigen processing that
protein antigens may differ in the stringency of processing
requirements. The fact that proteins differ widely in their
susceptibility to proteolysis supports this contention (29).
In conclusion, Ia-expressing L-cell transfectants are likely
to be very useful reagents not only in the analysis of
structure-function relationships of the Ia molecule but also in
the study of biochemical events associated with the phenom-
enon of antigen-specific MHC-restricted T-cell activation.
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